“…It is not possible from the present experiments to determine whether the PG analogues are acting directly on the proliferating cells or indirectly through, for example, changes in blood supply, intestinal motility or mastcell activity. PG F2, has been shown to act, in some cases at least, by raising intracellular levels of cyclic guanosine monophosphate (cGMP) (Kuehl et al, 1973) and 3 other agents that have been shown to stimulate the formation of cGMP, namely noradrenaline (Schultz et al, 1975), acetylcholine (Goldberg et al, 1973) and serotonin (Goldberg et al, 1974), as well as dibutyryl cGMP itself, have been shown to accelerate jejunal-crypt cell proliferation (Tutton & Helme, 1974;Tutton, 1974Tutton, , 1977Tutton & Barkla, 1979b). However, in the case of colonic adenocarcinoma, whilst both serotonin (Tutton & Barkla, 1978b) and dibutyryl cGMP (Tutton & Barkla, 1979b) promote cell division, the PG F2, analogue inhibits both cell division and xenograft growth.…”